Skip to main content

UBS Group AG

Position in ANIK — Anika Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ANIK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,133,287
+$203,715 QoQ
Shares Held
145,816
+9.6% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. ANIK ranks #33 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,133,287 145,816
2026-03-31 $1,929,572 133,074
2025-12-31 $274,316 28,545
2025-09-30 $270,560 28,783
2025-06-30 $963,488 91,067
2025-03-31 $211,201 14,052
2024-12-31 $1,131,196 68,724
2024-09-30 $186,237 7,540
2024-06-30 $179,564 7,089
2024-03-31 $475,716 18,729
2023-12-31 $347,740 15,346
2023-09-30 $174,674 9,376
2023-06-30 $606,347 23,339
2023-03-31 $572,849 19,946
2022-12-31 $737,336 24,910
2022-09-30 $137,587 5,781
2022-06-30 $110,617 4,956
2022-03-31 $732,282 29,163
2021-12-31 $1,066,872 29,776
2021-09-30 $869,798 20,437
2021-06-30 $437,877 10,115
2021-03-31 $798,055 19,565
2020-12-31 $44,626 986
2020-09-30 $74,778 2,113
2020-06-30 $44,332 1,175
2020-03-31 $199,940 6,916